Antalium Inc.
This article was originally published in Start Up
Executive Summary
In recent years, insights into the molecular biology of pain have given drug developers new targets, and companies are thronging to the field in the hope of developing side-effect free, non-narcotic analgesics. With the aim of developing novel drugs for pain based on novel ion channels, McGill University has spun-off Antalium Inc.